Skip to main content

Table 1 Patient characteristics

From: Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers

Patient characteristics

 

%

Number

  

Total included

42

100

Assessable for response

39

93

Sex

  

Male

31

74

Female

11

26

Age (years)

  

Median

64

 

Range

25–75

 

Performance status

  

0

18

43

1

17

41

2

7

17

MSKCC risk classification

  

Favorable

3

7

Intermediate

23

55

Poor

16

38

Previous treatments

  

Nephrectomy

35

83

Interferon-α

13

31

Interferon-α + chemotherapy

6

14

Radiotherapy

14*

33

  1. * Radiotherapy was directed against the primary tumor bed (as "adjuvant") in three patients; the rest (11 patients) received radiotherapy to the metastatic site (bone)
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us